Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes

Liver International, EarlyView.

https://onlinelibrary.wiley.com/doi/abs/10.1111/liv.13872?af=R

Source: Liver International - June 29, 2018 Category: Gastroenterology Authors: Chin ‐Hsiao Tseng Source Type: research

More News: Cancer & Oncology | Carcinoma | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Metformin | Urology & Nephrology